Glycorex Transplantation AB: Entering into an agreement with Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in life science research and clinical diagnostics products. Their customers include universities, research institutions, hospitals, food safety and environmental quality laboratories around the world. During the fall of 2022, a dialogue was initiated between Glycorex and Bio-Rad to evaluate Glycosorb® ABO as part of their manufacturing process for polyclonal reagents for rare blood groups. Donor plasma containing the specific antibody is used to produce these reagents. Since donors are typically of blood groups O, A, or